ÇÐȸ¼Ò°³

ÇÐȸ Çмú»ó

  • ´ëÇѼҾư¨¿°ÇÐȸ Çмú³í¹®»ó¿¡ ´ëÇÑ ±ÔÁ¤
    Á¦1Á¶ (¸íĪ)

    ´ëÇѼҾư¨¿°ÇÐȸ´Â ¡®Pediatric Infection and Vaccine¡¯Áö¿¡ °ÔÀçµÈ ¿øÀú¸¦ ½É»çÇÏ¿© ¸Å³â ¿ì¼öÇÑ ³í¹® 3Æí ÀÌ»óÀ» ¡°´ëÇѼҾư¨¿°ÇÐȸ-»ç³ëÇÇÆĽºÅ𸣠Çмú»ó¡±À¸·Î ¸íĪÇÏ¿© ½Ã»óÇÑ´Ù.

    Á¦ 2 Á¶ (´ë»ó ¹× ÃëÁö)

    Á¤È¸¿ø ÀÌ»óÀÇ È¸¿øÀ» ´ë»óÀ¸·Î ¾çÁúÀÇ Çй®Àû ¾÷Àû¿¡ ´ëÇÑ ½Ã»óÀ» ÅëÇØ ¡®Pediatric Infection and Vaccine¡¯Áö¿¡ Åõ°í¸¦ Àå·ÁÇÏ°í, ÇÐȸÀÇ Çмú È°µ¿°ú ÇÐȸÁöÀÇ ¼öÁØ Çâ»óÀ» µµ¸ðÇÏ°íÀÚ ÇÑ´Ù.

    Á¦ 3 Á¶ (Àç¿ø)

    º» Çмú»óÀº »ç³ëÇÇÆĽºÅð¸£(ÁÖ) ȸ»ç¿¡¼­ Áö¿øÇÑ´Ù. ±Ý¾×ÀÇ º¯µ¿À̳ª Áö±ÞÀÇ Áö¼Ó¼º¿¡ °üÇÑ »çÇ×Àº ÇÐȸ¿Í »ç³ëÇÇÆĽºÅð¸£(ÁÖ) ȸ»ç °£¿¡ »çÀü ÇùÀÇÇÑ´Ù.

    Á¦ 4 Á¶ (¼±Á¤ ±âÁØ)

    Àü³âµµ Ãá°è Çмú´ëȸ °³ÃÖ ½Ã±â¸¦ ±âÁØÀ¸·Î ¸Å 1³â°£ ´ëÇѼҾư¨¿°ÇÐȸ¿¡¼­ ¹ßÇàÇÑ ¡®Pediatric Infection and Vaccine¡¯Áö¿¡ °ÔÀçµÈ ¿øÀúµéÀ» ´ë»óÀ¸·Î ¼±Á¤ÇÑ´Ù.

    Á¦ 5 Á¶ (¼±Á¤ °úÁ¤)

    ÇмúÀ̻簡 ±¸¼ºÇÑ ½É»ç À§¿øȸ¸¦ Áß½ÉÀ¸·Î ¡®Pediatric Infection and Vaccine¡¯Áö¿¡ ÀϳⰣ °ÔÀçµÇ¾ú´ø ¿øÀúµéÀ» ½É»çÇÏ¿© 3Æí ÀÌ»óÀ» ¼±Á¤ÇÑ´Ù. ´Ü, ÇâÈÄ ¡®Pediatric Infection and Vaccine¡¯ÁöÀÇ ³â°£ ¹ß°£È£¼ö°¡ Áõ°¡½Ã¿¡´Â ´ë»ó ³í¹®µéÀ» ¼±º°ÇÏ¿© ¼±Á¤ÇÑ´Ù. ½É»ç°á°ú´Â ÇмúÀ̻簡 ÀÌ»çȸ¿¡ º¸°íÇÑ´Ù.

    Á¦ 6 Á¶ (½É»çÀ§¿øȸ)

    º» ÇÐȸÀÇ È¸Àå, ºÎȸÀå, ÇмúÀÌ»ç, °£ÇàÀÌ»ç, ±³À°¿¬¼öÀÌ»ç ¹× ±× ¿Ü ½É»çÀ§¿ø 2¸í(ÇмúÀ̻簡 À§ÃË)µî ÃÑ 7¸íÀ¸·Î ±¸¼ºµÈ ½É»çÀ§¿øȸ¿¡¼­ ½É»çÇÑ´Ù. ½É»çÀ§¿øÀÇ ÀÓ±â´Â 2³âÀ¸·Î ÇÑ´Ù.

    Á¦ 7 Á¶ (»ó±Ý)

    Çмú»óÀ¸·Î ¼±Á¤µÈ ³í¹® 1Æí´ç ¼ÒÁ¤ÀÇ »ó±ÝÀ» ´ëÇѼҾư¨¿°ÇÐȸ¿¡¼­ ¼ö¿©ÇÑ´Ù.

    Á¦ 8 Á¶ (½Ã»ó)

    Ãá°èÇмú´ëȸ ÃÑȸ¿¡¼­ ½Ç½ÃÇÑ´Ù.

    (ºÎÄ¢)

    Çмú»ó ½Ã»óÀº 2006³âºÎÅÍ ½ÃÇàÇÑ´Ù.

  • 2022³â Á¦17ȸ ´ëÇѼҾư¨¿°ÇÐȸ -»ç³ëÇÇÆĽºÅ𸣠Çмú³í¹®»ó
    1.

    ¼ö»ó³í¹® : Analysis of Central Line-associated Bloodstream Infection Among Infants in the Neonatal Intensive Care Unit: A Single Center Study (PIV 2021:28:133~143)

    ÀúÀÚ ¹× ¼Ò¼Ó : ÀÌÇöÁÖ/¼­¿ïÀÇ´ë

    2.

    ¼ö»ó³í¹® : Effect of Prenatal Antibiotic Exposure on Neonatal Outcomes of Preterm Infants (PIV 2021:28:149~159)

    ÀúÀÚ ¹× ¼Ò¼Ó : ÇãÁÖ¼±/°í·ÁÀÇ´ë

    3.

    ¼ö»ó³í¹® : Clinical and Epidemiological Characteristics of Common Human Coronaviruses in Children: A Single Center Study, 2015-2019 (PIV 2021:28:101~109)

    ÀúÀÚ ¹× ¼Ò¼Ó : ÃÖÀ±¿µ/±¹¸³Áß¾ÓÀÇ·á¿ø

  • 2021³â Á¦16ȸ ´ëÇѼҾư¨¿°ÇÐȸ -»ç³ëÇÇÆĽºÅ𸣠Çмú³í¹®»ó
    1.

    ¼ö»ó³í¹® : Clinical Characteristics of Human Parvovirus B19 Infection in Children

    ÀúÀÚ ¹× ¼Ò¼Ó : Kyo Jin Jo, Yeoun Joo Lee, Kyung Mi Park, Eu Jeen Yang, Sukdong Yoo, Taek Jin Lim and Su Eun Park Department of Pediatrics, Pusan National University Children's Hospital, Yangsan, the Republic of Korea

    2.

    ¼ö»ó³í¹® : Çѱ¹ÀÎÀÇ Epstein-Barr Virus Ç×ü ¾ç¼º·ü º¯È­¾ç»ó¿¡ ´ë ÇÑ ºÐ¼®: ´ÜÀϱâ°ü ¿¬±¸

    ÀúÀÚ ¹× ¼Ò¼Ó : ±è¼ö°æ1, ÃÖÁؽÄ1 , ±èµ¿¼·1, 2, °­Ã¶ÀÎ3, Á¤µÎ·Ã3, ¹é°æ¶õ3, °­Àº¼÷4, ±è¿¹Áø1
    1¼º±Õ°ü´ëÇб³ ÀÇ°ú´ëÇÐ, »ï¼º¼­¿ïº´¿ø ¼Ò¾Æû¼Ò³â°ú
    2°æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ, °æºÏ´ëÇб³ ¾î¸°À̺´¿ø ¼Ò¾Æû¼Ò³â°ú
    3¼º±Õ°ü´ëÇб³ ÀÇ°ú´ëÇÐ, »ï¼º¼­¿ïº´¿ø °¨¿°³»°ú
    4¼º±Õ°ü´ëÇб³ ÀÇ°ú´ëÇÐ, »ï¼º¼­¿ïº´¿ø Áø´Ü°Ë»çÀÇÇаú

    3.

    ¼ö»ó³í¹® : ÃÖ±Ù 5³â°£ ±¹³» ¼Ò¾Æû¼Ò³â¿¡¼­ ºÐ¸®µÈ Haemophilus influenzaeÀÇ Ç×»ýÁ¦ °¨¼ö¼º ºÐ¼®

    ÀúÀÚ ¹× ¼Ò¼Ó : ÀúÀÚ ¹× ¼Ò¼Ó: ÀÌÀºÅÃ1, ¹Ú¼¼¶ó1, ±è¹Ì³ª2, ÀÌÁø¾Æ1
    1¿ï»êÀÇ´ë ¼­¿ï¾Æ»êº´¿ø ¼Ò¾Æû¼Ò³â°ú,
    2¿ï»êÀÇ´ë ¼­¿ï¾Æ»êº´¿ø Áø´Ü°Ë»çÀÇÇаú

  • 2020³â Á¦15ȸ ´ëÇѼҾư¨¿°ÇÐȸ -»ç³ëÇÇÆĽºÅ𸣠Çмú³í¹®»ó
    1.

    ¼ö»ó³í¹® : ¼Ò¾Æû¼Ò³â °áÇÙ Á¢ÃËÀÚ °ËÁø ¹× Àẹ°áÇÙ°¨¿°ÀÇ Ä¡·á ÇöȲ: 2014-2017 ´ÜÀÏ ±â°ü ¿¬±¸ (PIV 2019;26:32~41)

    ÀúÀÚ ¹× ¼Ò¼Ó : Ȳ¿ìÁø1, ÀÌ°í¿î2, ±è¼ÒÇö2, Á¶Àº¿µ1
    1Ãæ³²´ëÇб³º´¿ø ¼Ò¾Æû¼Ò³â°ú,
    2Ãæ³²´ëÇб³º´¿ø È£Èí±â³»°ú

    2.

    ¼ö»ó³í¹® : Comparison of Split versus Subunit Seasonal Influenza Vaccine in Korean Children over 3 to under 18 Years of Age (PIV 2019;26:161~169)

    ÀúÀÚ ¹× ¼Ò¼Ó : Seah Kang1, Dong Ho Kim2, Byung Wook Eun3, Nam Hee Kim4, Eun Kyeong Kang5, Byong Sop Lee6,and Yun-Kyung Kim1
    1Department of Pediatrics, Korea University College of Medicine, Seoul, the Republic of Korea.
    2Department of Pediatrics, Korea Cancer Center Hospital, Seoul, the Republic of Korea.
    3Department of Pediatrics, Eulji General Hospital, Seoul, the Republic of Korea.
    4Department of Pediatrics, Inje University Ilsan Paik Hospital, Goyang, the Republic of Korea.
    5Department of Pediatrics, Dongguk University Ilsan Hospital, Goyang, the Republic of Korea.
    6Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, the Republic of Korea.

    3.

    ¼ö»ó³í¹® : Mycoplasma pneumoniae °¨¿°ÀÇ ½Å¼Ó Ç׿ø °Ë»ç Å°Æ® "Ribotest Mycoplasma"ÀÇ Áø´ÜÀû Æò°¡ (PIV 2019;26:81~88)

    ÀúÀÚ ¹× ¼Ò¼Ó : ¾ç¼ÛÀÌ1, Çѹ̼±2, ±è¼±Áß2, À̼º¿¬2, ÃÖÀºÈ­2
    1±¹¸³°æÂûº´¿ø ¼Ò¾Æû ¼Ò³â°ú,
    2¼­¿ï´ëÇб³ ¾î¸°À̺´ ¿ø ¼Ò¾Æû¼Ò³â°ú

  • 2019³â Á¦14ȸ ´ëÇѼҾư¨¿°ÇÐȸ -»ç³ëÇÇÆĽºÅ𸣠Çмú³í¹®»ó
    1.

    ¼ö»ó³í¹® : 6³â°£ ´ÜÀϱâ°ü¿¡¼­ ½ÃÇàµÈ ¼Ò¾Æ °£ÀÌ½Ä ÈÄ ¼¼±Õ °¨¿° ÇÕº´ÁõÀÇ Æ¯Â¡ (PIV 2018;25:82~90)

    ÀúÀÚ ¹× ¼Ò¼Ó : ±èÀçÃá1, ±è¼öÁö1, À±±â¿í1, 2, ÃÖÀºÈ­1, 2, À̳²ÁØ3, 4, ¼­°æ¼®3, 4, À̱¤¿õ3, 4, ÀÌȯÁ¾ 1, 2
    1¼­¿ï´ëÇб³ ¾î¸°À̺´¿ø ¼Ò¾Æû¼Ò³â°ú
    2¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç
    3¼­¿ï´ëÇб³º´¿ø ¿Ü°ú
    4¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç

    2.

    ¼ö»ó³í¹® : ÀӽŠÁß Tdap Á¢Á¾¿¡ ´ëÇÑ ÀӺεéÀÇ ÀνÄ, ŵµ ¹× Çൿ (PIV 2018;25:141~147)

    ÀúÀÚ ¹× ¼Ò¼Ó : À̽ÅÇý, Áøº¸°æ ,¹é°æ¼÷, Á¶¿ë¼±, ÀÌÅÃÁø
    Department of Pediatrics, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, the Republic of Korea

    3.

    ¼ö»ó³í¹® : Changes in Cytomegalovirus Seroprevalence in Korea for 21 Years: a Single Center Study (PIV 2018;25:123~131)

    ÀúÀÚ ¹× ¼Ò¼Ó : Sae Rom Choi1, Kyung-Ran Kim1, Dong Sub Kim1, Ji-Man Kang2, Sun Ja Kim3, Jong Min Kim4, Soo-young Oh5, Choel-In Kang6, Doo Ryeon Chung6, Kyong Ran Peck6, Eun-Suk Kang7, Yae-Jean Kim1
    1Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, the Republic of Korea
    2Department of Pediatrics, National Cancer Center, Goyang, the Republic of Korea
    3Department of Pediatrics, Cheju Halla General Hospital, Jeju Special Self-Governing Province, the Republic of Korea
    4Department of Pediatrics, Myungji Hospital, Goyang, the Republic of Korea
    5Department of Gynecology and Obstetrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, the Republic of Korea
    6Department of Infectious Diseases, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, the Republic of Korea
    7Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, the Republic of Korea

  • 2018³â Á¦13ȸ ´ëÇѼҾư¨¿°ÇÐȸ-»ç³ëÇÇÆĽºÅ𸣠Çмú»ó
    1.

    ¼ö»ó³í¹® : 18¼¼ ÀÌÇÏ ¹«ºñÁõ ȯÀÚ¿¡¼­ ¹ß»ýÇÑ Ä§½À¼º ¼¼±Õ °¨¿°Áõ¿¡ ´ëÇÑ ÈÄÇâÀû ¿¬±¸(PIV 2017;24:160~167)

    ÀúÀÚ ¹× ¼Ò¼Ó : ÃÖ¿ëÁØ, ¼­À¯¸®, ÀÌÁø¾Æ
    ¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¼­¿ï¾Æ»êº´¿ø ¼Ò¾Æû¼Ò³â°ú

    2.

    ¼ö»ó³í¹® : »ó±âµµ °¨¿°À¸·Î ÀÔ¿øÇÑ ¼Ò¾ÆȯÀÚ¿¡¼­ Ç×»ýÁ¦ »ç¿ë ¿¡ ´ëÇÑ ÈÄÇâÀû ºÐ¼® (PIV 2017;24:87~94)

    ÀúÀÚ ¹× ¼Ò¼Ó : ÀúÀÚ ¹× ¼Ò¼Ó: Á¤¹Î¿µ, ¹ÚÁöÇö, ¿ÀÁöÀº
    °í½Å´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç

    3.

    ¼ö»ó³í¹® : ´ÜÀÏ ±â°ü¿¡¼­ÀÇ ¼Ò¾Æ Ç÷¾×Á¾¾ç ȯÀÚ¿¡¼­ ¹ß»ýÇÑ ±ÕÇ÷ÁõÀÇ ¿øÀÎ±Õ ¹× ÀÓ»ó ¾ç»ó: 2011-2015³â(PIV 2017;24:71~78)

    ÀúÀÚ ¹× ¼Ò¼Ó : ¹ÚÁö¿µ1, À±±â¿í1, 2, °­ÇüÁø1, 2, ¹Ú°æ´ö1, 2, ½ÅÈñ¿µ1, 2, ÀÌȯÁ¾1, 2, ÃÖÀºÈ­1, 2
    ¼­¿ï´ëÇб³ ¾î¸°À̺´¿ø ¼Ò¾Æû¼Ò³â°ú1, ¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç2

  • 2017³â Á¦12ȸ ´ëÇѼҾư¨¿°ÇÐȸ-»ç³ëÇÇÆĽºÅ𸣠Çмú»ó
    1.

    ¼ö»ó³í¹® : Bacille Calmette-Gu?rin (BCG)¹é½Å Á¢Á¾ ÈÄ ¸²ÇÁÀý¿°ÀÇ ¹ß»ýºóµµ(PIV 2016;23:54-61)

    ÀúÀÚ ¹× ¼Ò¼Ó : ±èÀçÈ«1, À̱ÔÁø1,2, ±èÁ¾Çö1, ±è¼ºÁØ1, À̼ö¿µ1, ÀÌÇýÁø1, Á¶°æ¼ø1, ±Ç¿µÁÖ2, À̺´Âù2, Á¶»ó¹Î2, ÇÏÁ¤ÈÆ3, ÀÌÀ±°æ4, ½Â¼ÒÁø4, BCG ¸²ÇÁÀý¿°Á¶»çȸ
    (°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç1,¼º¼¼º´¿ø ¼Ò¾Æû¼Ò³â°ú2, ÇÏÁ¤ÈÆ ¼Ò¾Æû¼Ò³â°ú3, ÇѸ¶À½¼Ò¾Æû¼Ò³â°ú4)

    2.

    ¼ö»ó³í¹® : 2000-2014³â Çѱ¹¿¡¼­ ¼öÇàµÈ ¹é½ÅÀ¯¿ë¼º Æò°¡ ¿¬±¸(PIV 2016;23:117~127)

    ÀúÀÚ ¹× ¼Ò¼Ó : Â÷ÁöÇý1, ±èÇÑ¿ï2, À̼ҿµ1, 2, Á¶Çý°æ3, ¾ÈÁ¾±Õ1,±è°æÈ¿1, 2
    (ÀÌÈ­¿©ÀÚ´ëÇб³ ÀÇÇÐÀü¹®´ëÇпø ¼Ò¾Æ°úÇб³½Ç1, ÀÇ°úÇבּ¸¼Ò ¹é½ÅÈ¿´É¿¬±¸¼¾ÅÍ2, °¡ÃµÀÇ°úÇдëÇб³ ¼Ò¾Æ°úÇб³½Ç3)

    3.

    ¼ö»ó³í¹® : ¼Ò¾Æ ¾Ï ȯÀÚ¿¡¼­ ¹ß»ýÇÑ Bacillus cereus ±ÕÇ÷ÁõÀÇ ºÐÀÚ¿ª ºÐ¼®¿¡ °üÇÑ ¿¬±¸(PIV 2016;23:172~179)

    ÀúÀÚ ¹× ¼Ò¼Ó : ±èÁ¾¹Î1, 2, ¹Ú±â¼·3, À̺´±â4, ±è¼öÁø3, °­Áö¸¸2, ±è¾çÇö3, À¯°ÇÈñ2, ¼º±â¿õ2, ±¸È«È¸2, À̳²¿ë5, ±è¿¹Áø2
    ¼­³²´ëÇб³ ÀÇ°ú´ëÇÐ ¸íÁöº´¿ø ¼Ò¾Æû¼Ò³â°ú1, ¼º±Õ°ü´ëÇб³ ÀÇ°ú´ëÇÐ »ï¼º¼­¿ïº´¿ø ¼Ò¾Æû¼Ò³â°ú2, »ï¼º»ý¸í°úÇבּ¸¼Ò ÀÓ»óÀÇÇבּ¸¼¾ÅÍ3, ÁÁÀº°­¾Èº´¿ø¼Ò¾Æû¼Ò³â°ú4, ¼º±Õ°ü´ëÇб³ ÀÇ°ú´ëÇÐ »ï¼º¼­¿ïº´¿ø Áø´Ü°Ë»çÀÇÇаú5

  • 2016³â Á¦11ȸ ´ëÇѼҾư¨¿°ÇÐȸ-»ç³ëÇÇÆĽºÅ𸣠Çмú»ó
    1.

    ¼ö»ó³í¹® : ´ÙÁß±¸½½ Æó±¸±Õ Ç÷ûÇü ºÐ¼®¹ýÀÇ ±¹³» È®¸³°ú Àû¿ë ¿¬±¸(PIV 2015;22:97~105)

    ÀúÀÚ ¹× ¼Ò¼Ó : ±èÇÑ¿ï1,2, À̼ҿµ1,2, À̹̾Ö3, ±è°æÈ¿1,2
    (ÀÌÈ­¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç1, ÀÌÈ­¿©ÀÚ´ëÇб³ ÀÇ°úÇבּ¸¼Ò ¹é½ÅÈ¿´É¿¬±¸¼¾ÅÍ2, ÀÌÈ­¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐ Áø´Ü°Ë»çÀÇÇаú3)

    2.

    ¼ö»ó³í¹® : ¼öµÎ ¹ÙÀÌ·¯½º¿¡ ³ëÃâÈÄ 96½Ã°£ À̳»¿Í 96½Ã°£ ÀÌÈÄ¿¡ ¼öµÎ ¸é¿ª ±Û·ÎºÒ¸° Åõ¿©½Ã ¼öµÎ ¿¹¹æ È¿°ú¿¡ °üÇÑ ¿¬±¸(PIV 2015;22:55~62)

    ÀúÀÚ ¹× ¼Ò¼Ó : ±è¼±ÀÚ1, À̺´±â1,2, ±è¾çÇö3, ±è¼öÁø1, ±è¿¹Áø1
    (¼º±Õ°ü´ëÇб³ ÀÇ°ú´ëÇÐ »ï¼º¼­¿ïº´¿ø ¼Ò¾Æû¼Ò³â°ú1, ÁÁÀº°­¾Èº´¿ø ¼Ò¾Æû¼Ò³â°ú2, »ï¼º »ý¸í°úÇÐ ¿¬±¸¼Ò3)

    3.

    ¼ö»ó³í¹® : Ç×»ýÁ¦ »ç¿ë·® º¯È­¿¡ µû¸¥ ±×¶÷À½¼º±ÕÁÖÀÇ Ç×»ýÁ¦ ³»¼º·üÀÇ º¯È­ ¾ç»ó(PIV 2015;22:178~185)

    ÀúÀÚ ¹× ¼Ò¼Ó : ±è¼­Èñ, À¯¸®³ª, ÀÌÁø¾Æ
    (¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¼­¿ï¾Æ»êº´¿ø ¼Ò¾Æû¼Ò³â°ú)

  • 2015³â Á¦10ȸ ´ëÇѼҾư¨¿°ÇÐȸ-»ç³ëÇÇÆĽºÅ𸣠Çмú»ó
    1.

    ¼ö»ó³í¹® : µÎ °³ ´ëÇк´¿ø¿¡¼­ Áø´ÜµÈ Çе¿±â ¼Ò¾Æ ¹× û¼Ò³â Æó°áÇÙÀÇ ÀÓ»ó ¾ç»ó°ú Á¢ÃËÀÚ °ËÁøÀÇ ½ÇÅÂ(¼Ò¾Æ°¨¿° 2014;21:191~198)

    ÀúÀÚ ¹× ¼Ò¼Ó : ¹è¹ÌÇý*, ¼Ûº¸°æ*, ±è°æ¹Î*, ¼Õ½Â±¹*, ¹Ú¼öÀº**
    (ºÎ»ê´ëÇб³ ÀÇÇÐÀü¹®´ëÇпø ¼Ò¾Æû¼Ò³â°úÇб³½Ç)

    2.

    ¼ö»ó³í¹® : Çѱ¹Àο¡¼­ ¸é¿ª±Û·ÎºÒ¸°-ÀúÇ×¼º °¡¿Í»çÅ°º´ ȯÀÚÀÇ ¿¹Ãø(¼Ò¾Æ°¨¿° 2014;21:29~36)

    ÀúÀÚ ¹× ¼Ò¼Ó : ÃÖ¸íÇö*, ¹Úû¼ö*, ±èµ¿¼ö*, ±è±âȯ**
    (¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç, ¼¼ºê¶õ½º ¾î¸°À̺´¿ø ¼Ò¾Æû¼Ò³â°ú)

    3.

    ¼ö»ó³í¹® : ¼Ò¾Æ¿¡¼­ ¹ß»ýÇÑ A±º ¿¬¼â±¸±Õ¿¡ ÀÇÇÑ Ä§½À¼º ÁúȯÀÇ ÀÓ»óÀû Ư¼º ºÐ¼®(¼Ò¾Æ°¨¿° 2014;21:129~138)

    ÀúÀÚ ¹× ¼Ò¼Ó : ¾ç´©¸®*, ÃÖÀçÈ«*, Á¶Àº¿µ*, ÃÖÀºÈ­*, ÀÌȯÁ¾*, ÀÌÇöÁÖ¢Ó*
    (*¼­¿ï´ëÇб³ ¾î¸°À̺´¿ø ¼Ò¾Æû¼Ò³â°ú, ¢ÓºÐ´ç ¼­¿ï´ëÇб³º´¿ø ¼Ò¾Æû¼Ò³â°ú)

  • 2014³â Á¦9ȸ Çѱ¹¼Ò¾Æ°¨¿°º´ÇÐȸ-»ç³ëÇÇÆĽºÅ𸣠Çмú»ó
    1.

    ¼ö»ó³í¹® : ÀϺ»³ú¿° ¿¹¹æÁ¢Á¾ ÈÄ ¸é¿ª¿ø¼º ¹× ÁßÈ­Ç×ü Áö¼Ó·ü¿¡ °üÇÑ Á¶»ç(¼Ò¾Æ°¨¿° 2013;20:131~138)

    ÀúÀÚ ¹× ¼Ò¼Ó : ±èµ¿Çö, È«¿µÁø, ÀÌÈÆÀç*, ÃÖº¸À²¢Ó, ±èâÈÖ¢Ô, ¹ÚÀç¿Á¢Ô, °­ÁøÇÑ¡ò, ÃÖº´ÁØ¡ò, ±èÁ¾Çö¡ò, ¾È¿µ¹Î¡«, ÁÖ¿µ¶õ¢Ò, Á¤¿µÀÇ¢Ò, ÇÑ¸í±¹¢Ò
    (ÀÎÇÏ´ëÇб³ ÀÇÇÐÀü¹®´ëÇпø ¼Ò¾Æ°úÇб³½Ç, ÀÎÇÏ´ëÇб³ ÀÇÇÐÀü¹®´ëÇпø »çȸÀÇÇб³½Ç*, ÇѾç´ëÇб³ ÀÇ°ú´ëÇÐ ¿¹¹æÀÇÇб³½Ç¢Ó, ¼øõÇâ´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç¢Ô, °¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç¡ò, À»Áö´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç¡«, ±¹¸³º¸°Ç¿¬±¸¿ø ½Å°æ°è ¹ÙÀÌ·¯½º°ú¢Ò)

    2.

    ¼ö»ó³í¹® : ¼Ò¾Æû¼Ò³â¿¡¼­ÀÇ Àẹ°áÇÙ°¨¿° Áø´ÜÀ» À§ÇÑ °áÇÙ ÇǺιÝÀÀ°Ë»ç¿Í QuantiFERON¢ç-TB Gold In-Tube °Ë»ç¿ÍÀÇ °á°ú ºñ±³(¼Ò¾Æ°¨¿° 2013;20:17~27)

    ÀúÀÚ ¹× ¼Ò¼Ó : ÃÖÁ¾¿ø, ±è¹Î¼º, ±èÁ¾Çö (°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç)

    3.

    ¼ö»ó³í¹® : ¼Ò¾Æ¿¡¼­ÀÇ ¸¶ÀÌÄÚÇö󽺸¶ Æó·ÅÀÇ Áø´ÜÀ» À§ÇÑ Ç×ü °Ë»ç¿¡ °üÇÑ ¿¬±¸(¼Ò¾Æ°¨¿° 2013;20:71~80)

    ÀúÀÚ ¹× ¼Ò¼Ó : ±èÁø¼ö, °íÁ¤Èñ, ¿À¼ºÈñ (ÇѾç´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç)

  • 2013³â Á¦8ȸ Çѱ¹¼Ò¾Æ°¨¿°º´ÇÐȸ-»ç³ëÇÇÆĽºÅ𸣠Çмú»ó
    1.

    ¼ö»ó³í¹® : ¹éÀÏÇØ¿¡ ´ëÇÑ ¿¬·Éº° ¸é¿ªÇ÷ûÇÐÀû ¿¬±¸(¼Ò¾Æ°¨¿° 2012;19:55~60)

    ÀúÀÚ ¹× ¼Ò¼Ó : À̼ö¿µ*, ÃÖÀÇÀ±*, ±èÁÖ»ó¢Ó, ¾ÈÁßÇö¢Ó, ÃÖÁ¤Çö¢Ó, ¸¶»óÇõ¢Ô, ¹ÚÁؼö¡ò, ±èȲ¹Î¡«, °­ÁøÇÑ*
    (°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç*, ³»°úÇб³½Ç¢Ó, â¿øÆÄƼ¸¶º´¿ø ¼Ò¾Æû¼Ò³â°ú¢Ô, ¼øõÇâ´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç¡ò, ¿¬¼¼´ëÇб³ ¿øÁÖÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç¡«)

    2.

    ¼ö»ó³í¹® : ¿µÀ¯¾ÆÀÇ º¸À°½Ã¼³ ÀÌ¿ë°ú °¨¿°¼º Áúȯ ½ÇÅ ¿¬±¸(¼Ò¾Æ°¨¿° 2012;19:19~27)

    ÀúÀÚ ¹× ¼Ò¼Ó : ¾ÈÁ¾±Õ, ÃÖ¼º¿­, ±èµ¿¼ö, ±è±âȯ (¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç, ¼¼ºê¶õ½º ¾î¸°À̺´¿ø ¼Ò¾Æû¼Ò³â°ú)

    3.

    ¼ö»ó³í¹® : Çѱ¹ÀÇ ¼Ò¾Æ û¼Ò³â¿¡¼­ ÀÎÇ÷翣ÀÚ ¹é½ÅÀÇ È¿´ÉÆò°¡(¼Ò¾Æ°¨¿° 2012;19:149~156)

    ÀúÀÚ ¹× ¼Ò¼Ó : ±è½Â¿¬, ±è³²Èñ*, Àºº´¿í¢Ó, ±è¼ÒÈñ¢Ô, ¹Ú±â¿ø¡ò, ÀåÇö¿À¡«, °­Àº°æ¢Ò, ±èµ¿È£
    (¿øÀڷº´¿ø ¼Ò¾Æû¼Ò³â°ú, ÀÎÁ¦´ëÇб³ ÀÏ»ê¹éº´¿ø ¼Ò¾Æû¼Ò³â°ú*, °¡ÃµÀÇ°úÇдëÇб³ °¡Ãµ´ë±æº´¿ø ¼Ò¾Æû¼Ò³â°ú¢Ó, »ù¾È¾çº´¿ø¢Ô, ÀÌ¿ô»ç¶û ¼Ò¾Æû¼Ò³â°ú ÀÇ¿ø¡ò, ÇѺ° ¼Ò¾Æû¼Ò³â°úÀÇ¿ø¡«, µ¿±¹´ëÇб³ Àϻ꺴¿ø ¼Ò¾Æû¼Ò³â°ú¢Ò)

  • 2012³â Á¦7ȸ Çѱ¹¼Ò¾Æ°¨¿°º´ÇÐȸ-»ç³ëÇÇÆĽºÅ𸣠Çмú»ó
    1.

    ¼ö»ó³í¹® : ¼Ò¾Æ º¸Ä«¹ÙÀÌ·¯½º È£Èí±â °¨¿°ÁõÀÇ ¿ªÇÐÀû Ư¡(¼Ò¾Æ°¨¿° 2011;18:61~67)

    ÀúÀÚ ¹× ¼Ò¼Ó : ÃÖÀçÈ«, ¹éÁö¿¬, ÃÖÀºÈ­, ÀÌȯÁ¾ (¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç)

    2.

    ¼ö»ó³í¹® : ´ÜÀϱâ°ü¿¡¼­ ¼Ò¾Æ¾Ï ȯÀÚ¿¡¼­ È­Çпä¹ý Áß ¹ß»ýÇÑ ±ÕÇ÷ÁõÀÇ ÀÓ»ó ¾ç»ó(¼Ò¾Æ°¨¿° 2011;18:201~206)

    ÀúÀÚ ¹× ¼Ò¼Ó : Àå¹Ì¼±, ¼º±â¿õ, ±è¿¹Áø (¼º±Õ°ü´ëÇб³ ÀÇ°ú´ëÇÐ »ï¼º¼­¿ïº´¿ø ¼Ò¾Æ°úÇб³½Ç)

    3.

    ¼ö»ó³í¹® : ´ÜÀϱâ°ü ³» ¼Ò¾Æ¿¡¼­ Acinetobacter baumannii ÀÇ °¨¿°ÇöȲÀÇ ºÐ¼®(¼Ò¾Æ°¨¿° 2011;18:23~30)

    ÀúÀÚ ¹× ¼Ò¼Ó : ¹ÚÇýÁø, ±èÁ¤¹Î, ±è±âȯ, ±èµ¿¼ö (¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç, ¼¼ºê¶õ½º ¾î¸°À̺´¿ø ¼Ò¾Æû¼Ò³â°ú)

    4.

    ¼ö»ó³í¹® : ÀÏ°³ ´ëÇк´¿ø ÁßȯÀڽǿ¡ ÀÔ¿øÇÑ ¼Ò¾Æ ȯÀÚ¿¡¼­ ¹ß»ýÇÑ ¿ø³»°¨¿°ÀÇ ¾ç»ó (¼Ò¾Æ°¨¿° 2011;18:135~142)

    ÀúÀÚ ¹× ¼Ò¼Ó : ±è¼ö³², ¿øÁ¾º¹, Á¶ÇýÁ¤, Àºº´¿í, ½É¼Ò¿¬, ÃÖ´ö¿µ, ¼±¿ëÇÑ, Á¶°­È£, ¼Õµ¿¿ì, Â÷ÇÑ, ÀüÀλó (°¡Ãµ´ëÇб³ ÀÇÇÐÀü¹®´ëÇпø ¼Ò¾Æ°úÇб³½Ç)

  • 2011³â Á¦6ȸ Çѱ¹¼Ò¾Æ°¨¿°º´ÇÐȸ-»ç³ëÇÇÆĽºÅ𸣠Çмú»ó
    1.

    ¼ö»ó³í¹® : ÀÏ°³ ½Å»ý¾ÆÁßȯÀÚ½Ç ¹ÝÄÚ¸¶À̽ŠÀúÇ× À屸±Õ(VRE)ÀÇÀ¯Çà ¾ç»ó°ú Á¶Àý(¼Ò¾Æ°¨¿° 2010;17:1-8)

    ÀúÀÚ ¹× ¼Ò¼Ó : ¼­Á¤È£, ³²°¡¿¬, ¹Ú°æÈñ, º¯½Å¿¬, ¹Ú¼öÀº (ºÎ»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç)

    2.

    ¼ö»ó³í¹® : ¾î¸°ÀÌÁý ¼Ò¾Æ¿¡¼­ÀÇ È²»öÆ÷µµ¾Ë±ÕÀÇ ºñ°­ º¸±ÕÀ²¿¡ °üÇÑ ¿¬±¸(¼Ò¾Æ°¨¿° 2010;17:9-15)

    ÀúÀÚ ¹× ¼Ò¼Ó : ±è¿µ¹Î*,¢Ó, ¿ÀÁöÀº*, ±è¼ÒÈñ*, ÀÌÁø¾Æ¢Ô, ÃÖÀºÈ­*, ÀÌÁ¾È¯* (¼­¿ï´ëÇб³ ¾î¸°À̺´¿ø ¼Ò¾Æû¼Ò³â°ú*, ¿ï»ê µ¿°­º´¿ø ¼Ò¾Æû¼Ò³â°ú¢Ó, ºÐ´ç¼­¿ï´ëÇб³º´¿ø ¼Ò¾Æû¼Ò³â°ú¢Ô, ¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½ÇIV)

    3.

    ¼ö»ó³í¹® : 2005-2008³â ´ÜÀÏ ±â°üÀÇ ¼Ò¾Æ Ç÷¾× Á¾¾ç ȯÀÚ¿¡¼­ÀÇ ±ÕÇ÷Áõ ¾ç»ó: ¼Ò¾Æ Ç÷¾× Á¾¾ç ȯÀÚ¿¡¼­ÀÇ ±ÕÇ÷Áõ(¼Ò¾Æ°¨¿° 2010;17:36-48)

    ÀúÀÚ ¹× ¼Ò¼Ó : ±èÁöÇý, ±èÇüÁø, ÀÓ¿¬Á¤, ÀÌ¿µÈ£, ¿À¼ºÈñ (ÇѾç´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç)

    4.

    ¼ö»ó³í¹® : ¼Ò¾Æ ȯÀÚ¿¡¼­ ´Ù±ÕÇ÷Áõ¿¡ ´ëÇÑ ÀÓ»óÀû °íÂû(¼Ò¾Æ°¨¿° 2010;17:83-90)

    ÀúÀÚ ¹× ¼Ò¼Ó : ±èÁ¤¹Î, ¹ÚÇýÁø, ±è±âȯ, ±èµ¿¼ö (¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç, ¼¼ºê¶õ½º ¾î¸°À̺´¿ø ¼Ò¾Æû¼Ò³â°ú)

  • 2010³â Á¦5ȸ Çѱ¹¼Ò¾Æ°¨¿°º´ÇÐȸ-»ç³ëÇÇÆĽºÅ𸣠Çмú»ó
    1.

    ¼ö»ó³í¹® : À¯¾Æ¿ø¿¡ ´Ù´Ï´Â ¼Ò¾ÆÀÇ ±¸Àΰ­ ³» ¼ö¸·±¸±Õ º¸±ÕÀ²°ú Ç÷û(¼Ò¾Æ°¨¿° 2009;16:31~39)

    ÀúÀÚ ¹× ¼Ò¼Ó : ±è³²Èñ*,¢Ó, ÀÌÁø¾Æ¢Ó, ÀÌÁ¤¿ø¢Ô, À̼ö¿µ¡ò, ÃÖÀºÈ­¢Ó,¡«, ±è°æÈ¿¢Ô, ±èÀÇÁ¾¢Ò, °­ÁøÇÑ¡ò, ÀÌȯÁ¾¢Ó
    (ÀÎÁ¦´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç, ÀÏ»ê¹éº´¿ø ¼Ò¾Æû¼Ò³â°ú*, ¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç¢Ó, ÀÌÈ­¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç¢Ô, °¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç¡ò, ºÐ´ç¼­¿ï´ëÇб³º´¿ø ¼Ò¾Æ°ú¡«, ¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ °Ë»çÀÇÇб³½Ç¢Ò)

    2.

    ¼ö»ó³í¹® : Á¦ÁÖµµ ¼Ò¾Æ¿¡¼­ 2000³â 4¿ùºÎÅÍ 6¿ù±îÁö ¹ß»ýÇÑ Àå ¹ÙÀÌ·¯½º °¨¿°ÀÇ ÀÓ»ó ¾ç»ó ¹× Àå ¹ÙÀÌ·¯½º 71Çü °¨¿°ÀÇ Æ¯Â¡(¼Ò¾Æ°¨¿° 2009;16:73~79)

    ÀúÀÚ ¹× ¼Ò¼Ó : À±¼ÒÈñ, ±èÀÇÁ¾*, È«Á¤¿¬¢Ó (Á¦ÁÖ´ëÇб³ ÀÇ°ú´ëÇÐ ºÎ¼Óº´¿ø ¸¶Ãë°ú, ¼­¿ï´ëÇк´¿ø Áø´Ü°Ë»çÀÇÇб³½Ç*, Á¦ÁÖ´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç¢Ó)

    3.

    ¼ö»ó³í¹® : ¼Ò¾Æ Ȳ»öÆ÷µµ¾Ë±Õ °¨¿°ÁõÀÇ ÀÓ»ó ¾ç»ó¿¡ ´ëÇÑ °íÂû: Áö¿ª»çȸ °ü·Ã ¸ÞƼ½Ç¸° ³»¼º Ȳ»öÆ÷µµ¾Ë±Õ °¨¿°À» Áß½ÉÀ¸·Î(¼Ò¾Æ°¨¿° 2009;16:150~161)

    ÀúÀÚ ¹× ¼Ò¼Ó : ÃÖ¿µÁØ, À̼ҿ¬, ¼ºÁö¿¬, ¾ç¹Ì¾Ö, ÀÌÁØÈ£, ¿ÀÁöÀº, ÀÌÁø¾Æ, ÃÖÀºÈ­, ÀÌȯÁ¾ (¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç)

    4.

    ¼ö»ó³í¹® : ¿µ¾Æ ¹éÀÏÇØÀÇ ÀÓ»ó ¾ç»ó(¼Ò¾Æ°¨¿° 2009;16:167~174)

    ÀúÀÚ ¹× ¼Ò¼Ó : ±è¼øÁÖ, ±è»óÀº, ±èÁ¾Çö, ÀÌÁ¤Çö, ¿ÀÁøÈñ, °í´ë±Õ, ¼ºÈ­¿µ*, À¯À翬* (°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç, Áúº´°ü¸®º»ºÎ ±¹¸³º¸°Ç¿¬±¸¿ø °¨¿°º´¼¾ÅÍ °áÇÙÈ£Èí±â¼¼±Õ°ú*)

  • 2009³â Á¦4ȸ Çѱ¹¼Ò¾Æ°¨¿°º´ÇÐȸ-»ç³ëÇÇÆĽºÅ𸣠Çмú»ó
    1.

    ¼ö»ó³í¹® : ÁßÀÌ¿° ȯ¾ÆÀÇ ÀÌ·ç¿¡¼­ ºÐ¸®µÈ Æ󱸱ÕÀÇ Ç÷ûÇü ºÐÆ÷(2001-2006) (¼Ò¾Æ°¨¿° 2008;15:45~51)

    ÀúÀÚ ¹× ¼Ò¼Ó : ÀÌÅÃÁø, ÀüÁø°æ*, ±è±âȯ*, ±è±âÁÖ*, ±èµ¿¼ö* (Æ÷õÁß¹®ÀÇ°ú´ëÇб³ ¼Ò¾Æ°úÇб³½Ç, ¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç*)

    2.

    ¼ö»ó³í¹® : Æó°áÇÙ Á¢ÃË·ÂÀ» °¡Áø ¼Ò¾Æ¿¡¼­ Àẹ °áÇÙ °¨¿°ÀÇ Áø´ÜÀ» À§ÇÑ °áÇ٠ƯÀÌÇ׿ø ÀÚ±Ø ÀÎÅÍÆä·Ð-°¨¸¶ ÃøÁ¤ÀÇ À¯¿ë¼º(¼Ò¾Æ°¨¿° 2008:15;52-58)

    ÀúÀÚ ¹× ¼Ò¼Ó : ¼ºÁö¿¬, ±èÁÖÈ­, ¾ç¹Ì¾Ö, ±è¼ÒÈñ, Àºº´¿í*, ±è³²Èñ¢Ó, ¹Ú°æ¿î¢Ô, ÀÌÁø¾Æ, ÃÖÀºÈ­, ÀÌȯÁ¾ (¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç, °¡ÃµÀÇ°ú´ëÇб³ ±æº´¿ø ¼Ò¾Æû¼Ò³â°ú*, ÀÎÁ¦´ëÇб³ ÀÏ»ê¹éº´¿ø ¼Ò¾Æû¼Ò³â°ú¢Ó, ºÐ´ç ¼­¿ï´ëÇб³º´¿ø Áø´Ü°Ë»çÀÇÇаú¢Ô)

    3.

    ¼ö»ó³í¹® : Mannose Binding Lectin À¯ÀüÀÚ ´ÙÇü¼º°ú °¡¿Í»ç³¢º´ ¹ßº´ÀÇ ¿¬°ü¼º¿¡ °üÇÑ Pilot ¿¬±¸ (¼Ò¾Æ°¨¿° 2008:15;195-201)

    ÀúÀÚ ¹× ¼Ò¼Ó : ÃÖÀºÈ­, ±èÈñ¼·*, ÀÌȯÁ¾, ÃÖÁ¤¿¬ (¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç, µ¿±¹´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç*)

  • 2008³â Á¦3ȸ Çѱ¹¼Ò¾Æ°¨¿°º´ÇÐȸ-»ç³ëÇÇÆĽºÅ𸣠Çмú»ó
    1.

    ¼ö»ó³í¹® : ´ÜÀÏ ±â°ü¿¡¼­ ¼Ò¾Æ ȯÀÚµéÀÇ ÀÓ»ó°Ëü·ÎºÎÅÍ ºÐ¸®µÈ vancomycin³»¼º À屸±Õ¿¡ ´ëÇÑ ÀÓ»óÀû °íÂû(¼Ò¾Æ°¨¿° 2007:14;162-170)

    ÀúÀÚ ¹× ¼Ò¼Ó : ¹Ú¿©ÈÆ, ±è±âÁÖ, ±è±âȯ, ÀüÁø°æ, ÀÌÅÃÁø, ±èµ¿¼ö, ¹ÚÀº¼÷* (¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç, °¨¿°°ü¸®½Ç*)

    2.

    ¼ö»ó³í¹® : RSV °¨¿°ÀÇ Á¶±â Áø´Ü kit "¹ÙÀÌ¿À¶óÀÎ ¾Ë¿¡½ººêÀÌ"ÀÇ Æò°¡(¼Ò¾Æ°¨¿° 2007:14;91-96)

    ÀúÀÚ ¹× ¼Ò¼Ó : ±è¼ÒÈñ, ¼ºÁö¿¬, ¾ç¹Ì¾Ö, Àºº´¿í, ÀÌÁø¾Æ, ÃÖÀºÈ­, ÀÌȯÁ¾ (¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç)

    3.

    ¼ö»ó³í¹® : ¼Ò¾Æ human bocavirusÀÇ ÀÓ»óÀû °íÂû(¼Ò¾Æ°¨¿° 2007:14;136-137)

    ÀúÀÚ ¹× ¼Ò¼Ó : ÃÖâ¼±, ¹ÚÂùÈñ, Á¤±Ç, ÀÌ°Ç, ¼±±Ô±Ù, ±èÀº¿µ, ±è°æ½É, ±è¿ë¿í, ¼­ÁøÁ¾*, Á¤À±¼®¢Ó(±¤Áֱ⵶º´¿ø ¼Ò¾Æû¼Ò³â°ú, ±¤ÁÖ±¤¿ª½Ã º¸°Çȯ°æ¿¬±¸¿ø*, Áúº´°ü¸®º»ºÎ ±¹¸³º¸°Ç¿¬±¸¿ø¢Ó)

  • 2007³â Á¦2ȸ Çѱ¹¼Ò¾Æ°¨¿°º´ÇÐȸ-»ç³ëÇÇÆĽºÅ𸣠Çмú»ó
    1.

    ¼ö»ó³í¹® : ½ÉÇÑ Respiratory syncytial virus °¨¿°Áõ°ú ¼±Ãµ¼º ¸é¿ª¿¡ °ü·ÃµÈ À¯ÀüÀû ¼ÒÀο¡ °üÇÑ ¿¬±¸: Mannose Binding Lectin À¯ÀüÀÚ ´ÙÇü¼º (¼Ò¾Æ°¨¿° 2006;13:63-70)

    ÀúÀÚ ¹× ¼Ò¼Ó : ÃÖÀºÈ­, ±èÈñ¼·*, À±º¸¿µ, ÃÖ½ÂÀº, ³ª¼ÛÀÌ, ±èµ¿È£, ¹Ú±â¿ø, ÀÌȯÁ¾(¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç, *µ¿±¹´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç)

    2.

    ¼ö»ó³í¹® : 15³â°£(1991-2005³â) ¿ì¸®³ª¶ó ¼Ò¾Æ¿¡¼­ ºÐ¸®µÈ Æ󱸱ÕÀÇ Ç÷ûÇü ºÐÆ÷ÀÇ º¯È­ (¼Ò¾Æ°¨¿° 2006;13:89-98)

    ÀúÀÚ ¹× ¼Ò¼Ó : ±è¼ÒÈñ, ¼ÛÀº°æ, ÀÌÁØÈ£, ±è³²Èñ, ÀÌÁø¾Æ, ÃÖÀºÈ­, ÀÌȯÁ¾(¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç)

    3.

    ¼ö»ó³í¹® : Multiplex Latex Bead À¯¼¼Æ÷ ºÐ¼®±â ±â¹ý°ú Quellung ¹ÝÀÀÀ» ÀÌ¿ëÇÑ Æó±¸±Õ Ç÷ûÇü ºÐ¼® ºñ±³ (¼Ò¾Æ°¨¿° 2006;13:99-105)

    ÀúÀÚ ¹× ¼Ò¼Ó : ÃÖ°æ¹Î, ¿¬¼öÀÎ*, ±èÀº¼÷*, ½ÅÀü¼ö*, ¿ëµ¿Àº+, ÀÌ°æ¿ø+, ±èµ¿¼ö(¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç, *¹Ì»ý¹°Çб³½Ç, +Áø´Ü°Ë»çÀÇÇаú)

    4.

    ¼ö»ó³í¹® : ħ½ÀÀû ¹× ºñħ½ÀÀû °¨¿° ȯÀÚ¿¡¼­ ºÐ¸®µÈ A±º ¿¬±¸±ÕÀÇ T Ç÷ûÇü°ú emm À¯ÀüÀÚÇüÀÇ ºñ±³ ¿¬±¸ (¼Ò¾Æ°¨¿° 2006;13:106-114)

    ÀúÀÚ ¹× ¼Ò¼Ó : ÇÑ¿øÈ£, ±è¼¼Áø, °íÇѼ®, Á¤»çÁØ, Â÷¼ºÈ£, ÀÌÈñÁÖ*, ÀÌ°æ¿ø+(°æÈñ´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç, *Áø´Ü°Ë»çÀÇÇб³½Ç, +¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ Áø´Ü°Ë»çÀÇÇб³½Ç)

  • 2006³â Á¦1ȸ Çѱ¹¼Ò¾Æ°¨¿°º´ÇÐȸ-»ç³ëÇÇÆĽºÅ𸣠Çмú»ó
    1.

    ¼ö»ó³í¹® : 2003-2004³â °æ³² ¸¶»ê Áö¿ª¿¡¼­ ºÐ¸®µÈ A±º ¿¬¼â±¸±ÕÀÇ T Ç÷ûÇü°ú emm À¯ÀüÀÚÇüÀÇ °èÀýº° ºÐÆ÷(¼Ò¾Æ°¨¿° 2005;12:52-60)

    ÀúÀÚ ¹× ¼Ò¼Ó : ÀüÈ£»ó, ¹ÚÈ­Áø, ÀÌÈñÁÖ*, ¸¶»óÇõ¢Ó, Â÷¼ºÈ£(°æÈñ´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç, Áø´Ü°Ë»çÀÇÇб³½Ç*, â¿øÆÄƼ¸¶º´¿ø ¼Ò¾Æ°ú¢Ó)

    2.

    ¼ö»ó³í¹® : ¼Ò¾Æ ħ½À¼º Æó±¸±Õ °¨¿°ÁõÀÇ ¿ªÇÐÀû Ư¼º°ú ÀÓ»ó ¾ç»ó(¼Ò¾Æ°¨¿° 2005;12:140-148)

    ÀúÀÚ ¹× ¼Ò¼Ó : ¼ÛÀº°æ, ÀÌÁØÈ£, ±è³²Èñ, ÀÌÁø¾Æ, ±èµ¿È£*, ¹Ú±â¿ø¢Ó, ÃÖÀºÈ­, ÀÌȯÁ¾(¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç, ¿øÀڷº´¿ø ¼Ò¾Æ°ú*, ±¹¸³°æÂûº´¿ø ¼Ò¾Æ°ú¢Ó)

    3.

    ¼ö»ó³í¹® : Çϱ⵵ °¨¿° ȯ¾Æ¿¡¼­ ºÐ¸®µÈ Adenovirus 1, 2, 5 Ç÷ûÇüÀÇ À¯ÀüüÇü ºÐ¼®(¼Ò¾Æ°¨¿° 2005;12:166-177)

    ÀúÀÚ ¹× ¼Ò¼Ó : ¹Ú±â¿ø, ÃÖÀºÈ­*, Á¤ÁöÅ¢Ó, ÀÌȯÁ¾*, ¹Ú±âÈ£¢Ô(±¹¸³°æÂûº´¿ø ¼Ò¾Æ°ú, ¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç*, °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç¢Ó, ¼­¿ï´ëÇб³º´¿ø ÀÓ»óÀÇÇבּ¸¼Ò¢Ô)

    4.

    ¼ö»ó³í¹® : ±¹³»¿¡¼­ 2005³â¿¡ ½Ç½ÃÇÑ ¿¬·Éº° AÇü °£¿°¹ÙÀÌ·¯½º Ç×üº¸À¯À²(¼Ò¾Æ°¨¿° 2005;12:186-194)

    ÀúÀÚ ¹× ¼Ò¼Ó : ÃÖÇýÁø*, À̼ö¿µ, ¸¶»óÇõ*, ±èÁ¾Çö, ÇãÀç±Õ, °­ÁøÇÑ(°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç*, ÆÄƼ¸¶º´¿ø ¼Ò¾Æ°ú)